Adrià Tort Merino
Adrià Tort Merino
Alzheimer's disease and other cognitive disorders unit, Neurology Service, Hospital Clínic Barcelona
Verified email at
Cited by
Cited by
Informants’ perception of subjective cognitive decline helps to discriminate preclinical Alzheimer’s disease from normal aging
N Valech, MA Mollica, J Olives, A Tort, J Fortea, A Lleo, SS Belén, ...
Journal of Alzheimer's Disease 48 (s1), S87-S98, 2015
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
A Antonell, A Tort-Merino, J Ríos, M Balasa, S Borrego-Écija, JM Auge, ...
Alzheimer's & Dementia, 2019
Executive and language subjective cognitive decline complaints discriminate preclinical Alzheimer’s disease from normal aging
N Valech, A Tort-Merino, N Coll-Padrós, J Olives, M León, L Rami, ...
Journal of Alzheimer's Disease 61 (2), 689-703, 2018
Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment
N Falgàs, R Sánchez-Valle, N Bargalló, M Balasa, G Fernández-Villullas, ...
NeuroImage: Clinical 23, 101927, 2019
The hippocampal longitudinal axis—relevance for underlying tau and TDP-43 pathology
A Llado, A Tort-Merino, R Sanchez-Valle, N Falgas, M Balasa, B Bosch, ...
Neurobiology of aging 70, 1-9, 2018
Early detection of learning difficulties when confronted with novel information in preclinical Alzheimer’s disease stage 1
A Tort-Merino, N Valech, C Penaloza, P Grönholm-Nyman, M Leon, ...
Journal of Alzheimer's Disease 58 (3), 855-870, 2017
Subtle visuomotor difficulties in preclinical A lzheimer's disease
MA Mollica, J Navarra, I Fernández‐Prieto, J Olives, A Tort, N Valech, ...
Journal of neuropsychology 11 (1), 56-73, 2017
Clinical applicability of diagnostic biomarkers in early‐onset cognitive impairment
N Falgàs, A Tort‐Merino, M Balasa, S Borrego‐Écija, M Castellví, J Olives, ...
European journal of neurology 26 (8), 1098-1104, 2019
Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
N Falgàs, M Ruiz‐Peris, A Pérez‐Millan, R Sala‐Llonch, A Antonell, ...
Human brain mapping 41 (8), 2004-2013, 2020
Tau protein is associated with longitudinal memory decline in cognitively healthy subjects with normal Alzheimer’s disease cerebrospinal fluid biomarker levels
A Tort-Merino, J Olives, M León, C Peñaloza, N Valech, ...
Journal of Alzheimer's Disease 70 (1), 211-225, 2019
Digital biomarker‐based individualized prognosis for people at risk of dementia
M Buegler, RL Harms, M Balasa, IB Meier, T Exarchos, L Rai, R Boyle, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020
Associations between the subjective cognitive Decline-Questionnaire’s scores, gray matter volume, and amyloid-β levels
N Valech, G Sánchez-Benavides, A Tort-Merino, N Coll-Padrós, J Olives, ...
Journal of Alzheimer's Disease 72 (4), 1287-1302, 2019
Diagnostic accuracy of MRI visual rating scales in the diagnosis of early onset cognitive impairment
N Falgàs, M Balasa, N Bargalló, S Borrego-Écija, O Ramos-Campoy, ...
Journal of Alzheimer's Disease 73 (4), 1575-1583, 2020
Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-β positivity
MA Mollica, A Tort-Merino, J Navarra, I Fernández-Prieto, N Valech, ...
Cortex 121, 117-124, 2019
Accelerated long‐term forgetting over three months in asymptomatic APOE ɛ4 carriers
A Tort‐Merino, M Laine, N Valech, J Olives, M León, M Ecay‐Torres, ...
Annals of Clinical and Translational Neurology 8 (2), 477-484, 2021
Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants
O Ramos-Campoy, A Antonell, N Falgàs, M Balasa, S Borrego-Écija, ...
Neurobiology of aging 93, e1-e9, 2020
Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
J Contador, A Pérez-Millán, A Tort-Merino, M Balasa, N Falgàs, J Olives, ...
NeuroImage: Clinical 32, 102804, 2021
Agreement of amyloid PET and CSF biomarkers in a clinical cohort.
N Guillén, J Contador, A Tort-Merino, M Balasa, NF Martínez, J Olives, ...
2021 Alzheimer's Association International Conference, 2021
Impact of COVID-19 pandemic in an early-onset dementia clinic in Barcelona
J Contador, N Guillén, A Tort-Merino, M Balasa, NF Martínez, J Olives, ...
2021 Alzheimer's Association International Conference, 2021
Accelerated long‐term forgetting in individuals with subjective cognitive decline and amyloid‐β positivity
A Tort‐Merino, N Valech, M Laine, J Olives, M León, M Ecay‐Torres, ...
International Journal of Geriatric Psychiatry 36 (7), 1037-1049, 2021
The system can't perform the operation now. Try again later.
Articles 1–20